文献速递口腔修复与种植

高龄和/或全身系统性疾病对种植体存活的影响:系统综述与Meta分析

Effect of advanced age and/or systemic medical conditions on dental implant survival: A systematic review and meta-analysis.
PubMed 文献 · Clin Oral Implants Res · 2018-01-01

该系统综述与Meta分析评估了老年患者(≥75岁)及七种常见全身系统性疾病患者的种植体存活率。共纳入60项研究,Meta分析显示负重后1年和5年种植体总存活率分别为97.3%和96.1%。结论认为老年患者种植修复可行,全身疾病患者需评估风险。

要点

  • 老年(≥75岁)患者种植体存活率高,修复可行。
  • 心血管疾病、帕金森病或2型糖尿病患者种植体存活率较高。
  • 接受放疗的癌症患者及高剂量抗骨吸收治疗者种植风险高。

核心结论

  • 老年患者种植修复是可预期的治疗选择,种植体存活率非常高。
  • 功能和社会心理获益应超过常见医学状况的相关风险。

研究设计与样本

  • 系统综述与Meta分析:检索6,893项研究,最终纳入60项。
  • 对负重后种植体存活率进行Meta分析,对系统性疾病及治疗影响进行定性分析。

主要发现

  • 固定效应模型显示负重后1年总种植体存活率为97.3%(95%CI:94.3–98.7;研究数=7)。
  • 负重后5年总种植体存活率为96.1%(95%CI:87.3–98.9;研究数=3)。
  • 心血管疾病患者种植体存活率可能不低于健康患者。
  • 帕金森病或2型糖尿病患者报告了高种植体存活率。
  • 癌症患者种植体存活受负面影响,尤其是放疗;高剂量抗骨吸收治疗(ART)的骨转移患者并发症风险高;低剂量ART治疗骨质疏松者存活率高。

关键数值与推荐

  • 1年种植体存活率97.3%(95%CI:94.3–98.7;研究数=7)。
  • 5年种植体存活率96.1%(95%CI:87.3–98.9;研究数=3)。
  • 无证据支持痴呆、呼吸系统疾病、肝硬化或骨关节炎患者的种植体存活情况。

临床怎么用

  • 老年患者可考虑种植修复,但需综合评估系统性疾病及治疗。
  • 癌症放疗患者及高剂量抗骨吸收治疗者应谨慎评估种植风险。
  • 对痴呆、呼吸系统疾病、肝硬化或骨关节炎患者,缺乏证据指导种植决策。

局限性

  • 部分系统性疾病(痴呆、呼吸系统疾病、肝硬化、骨关节炎)缺乏种植体存活证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: his review evaluated implant survival in geriatric patients (≥75 years) and/or the impact of systemic medical conditions. MATERIALS AND METHODS: Systematic literature searches were performed to identify studies reporting on geriatric subjects with dental implants and on implant patients who had any of the seven most common systematic conditions among geriatric patients. Meta-analyses were performed on the postloading implant survival rates. The impact of systemic medical conditions and their respective treatment was qualitatively analyzed. RESULTS: A total of 6,893 studies were identified; of those, 60 studies were included. The fixed-effects model revealed an overall implant survival of 97.3% (95% CI: 94.3, 98.7; studies = 7) and 96.1% (95% CI: 87.3, 98.9; studies = 3), for 1 and 5 years, respectively. In patients with cardiovascular disease, implant survival may be similar or higher compared to healthy patients. High implant survival rates were reported for patients with Parkinson's disease or diabetes mellitus type II. In patients with cancer, implant survival is negatively affected, namely by radiotherapy. Patients with bone metastases receiving high-dose antiresorptive therapy (ART) carry a high risk for complications after implant surgery. Implant survival was reported to be high in patients receiving low-dose ART for treatment of osteoporosis. No evidence was found on implant survival in patients with dementia, respiratory diseases, liver cirrhosis, or osteoarthritis. CONCLUSIONS: Implant prostheses in geriatric subjects are a predictable treatment option with a very high rate of implant survival. The functional and psychosocial benefits of such intervention should outweigh the associated risks to common medical conditions.

来源:Clin Oral Implants Res,查看原文。版权归原作者所有。

引用

  1. Schimmel M, Srinivasan M, McKenna G, et al. Effect of advanced age and/or systemic medical conditions on dental implant survival: A systematic review and meta-analysis. Clin Oral Implants Res. 2018. PMID: 30328186. doi:10.1111/clr.13288

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。